It is generally understood that an innovation effort, along with the innovator, in an established company needs protection. How that protection is provided is another thing.
How
protection is provided to innovations may be similar to the dilemma parents
face in their attempts to regulate how much, and when, their kids are exposed
to the various realities of life. Too
much protection can leave a child dependent and ill prepared. Too little protection can push a child beyond
what they can handle emotionally and psychologically.
The
same can be said for nascent innovations. On one hand, under exposure to the external circumstances and realities
of the intended user can stunt the development of the innovation. On the other hand, over or premature exposure
to these realities risks a “failure” so visible that few have the persistence
or courage to learn from it.
Our
society’s increasing propensity to give its children antibiotics at the first
sign of a cold or flu was the topic of a recent conversation I had with a
veteran innovation sponsor and “midwife.”
Both of us were wondering outloud whether we are, in effect, weakening
the next generation’s resistance to disease. It is a difficult dilemma for parents these days. With all the pharmacological options
available to us—even anti-bacterial soaps—are we, in effect, contributing
to a quietly developing longer term problem to address a short term fear for
our children’s health? Might many of us
as innovators be guilty of something similar with innovations brewing in the
labs and internal development efforts of our companies?
Gaining
and maintaining the right amount of exposure at the right time for the
iterative nurture and development most innovations is an art, requiring the
experienced counsel of innovation veterans.
Over exposure to internal influences and under exposure to external
realities can kill an innovation before it has the time to see the light of
day. However, over exposure to external
realities and under exposure to internal influences can stimulate the
“not-invent-here syndrome” and various other “autoimmune” responses. So how do you
find the right balance?
One
of our clients in the consumer food business looks to what they refer to as
“discovery channels” to provide the right balance of hard external realities
and sheltered nurture for their not-quite-ready-for-prime-time
innovations. In this case the “discovery
channel” is a retailer whose requirement for “turns” is modest enough and who
is willing to allow the manufacturer direct contact with their customers and
floor personnel to enable unmediated access to feedback.
One
of the advantages of such a “discovery channel” is that the feedback is real,
not simulated. Another advantage is that
a “natural” demand can be more realistically estimated at least for the early
stages of a new product’s introduction, as consumers discover the product more
or less on their own. In other words,
“discovery channels” can provide the innovating company a better
signal-to-noise ratio, while avoiding the distorting influences of the
typically promotional atmosphere of the mass marketplaces.
While
the form of the “discovery channel” this consumer business uses may be more
applicable to consumer package goods businesses, the principles are potentially
applicable in other types of industries as well. Software companies use so-called “beta-sites”
to test their programs in use. Equipment
manufacturers use “pilot” projects to gain experience that can be trusted. Whatever the particular form of “discovery
channel,” finding such a venue for each innovation can provide the innovation
with sufficient experience in establishing its own identity; it can then hold
its own in the inevitable sibling rivalry for resources within the company’s
established businesses.
This article by Lanny Vincent originally appeared in Innovating Perspectives in November 2003. For other issues of our newsletter,
please go to www.innovationsthatwork.com or call (415) 387-1270.
© 2013 Vincent & Associates, Ltd.